Using human pancreatic samples and mouse models, the HSPH researchers — with colleagues from Harvard Medical School, the Broad Institute of Harvard and MIT, and the Université Libre de Bruxelles — sought to tease apart the mechanisms of
beta cell failure in T1D.
Not exact matches
But in patients with type 1 diabetes,
beta -
cell replacement therapy is likely doomed to
failure because the new
cells might fall victim to the same autoimmunity that destroyed the original
cells.
At the root of that is the
failure of
beta cells, whose job it is to produce insulin.
Partial clinical hold on high dose SGT - 001 resolved, additional information requested on full clinical hold NIH grant will further development of replacement
beta cells for type 1 and type 2 diabetes New trial will assess MSCs to improve heart function in heart
failure patients ReNeuron wins grant for retinal
cell therapy development